J. Cucchiaro

发表

The dorsal lateral geniculate nucleus of the normal ferret and its postnatal development

R. Guillery, D. Linden, J. Cucchiaro, 1981, The Journal of comparative neurology.

Morphology and axonal projection patterns of individual neurons in the cat perigeniculate nucleus.

A L Humphrey, A. L. Humphrey, S. Sherman, 1991, Journal of neurophysiology.

Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.

J. Cucchiaro, A. Loebel, Mitsutaka Nakamura, 2009, The Journal of clinical psychiatry.

Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.

T. Ketter, L. Citrome, J. Cucchiaro, 2014, Journal of affective disorders.

Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study

R. Findling, R. Goldman, J. Cucchiaro, 2017, Journal of child and adolescent psychopharmacology.

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

J. Cucchiaro, S. Potkin, A. Loebel, 2011, Schizophrenia Research.

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.

S. Stahl, J. Cucchiaro, A. Pikalov, 2013, The Journal of clinical psychiatry.

1053 – In Vitro Receptor-binding Profile Of Lurasidone And Other Commonly-used Antipsychotics

S. Stahl, J. Cucchiaro, A. Loebel, 2013, European Psychiatry.

1051 – Lurasidone In The Treatment Of Early-stage Schizophrenia: a Post-hoc Analysis Of Three Pooled Acute Treatment Studies

J. Lieberman, J. Cucchiaro, A. Pikalov, 2013, European Psychiatry.

Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study.

J. Kane, R. Goldman, L. Citrome, 2016, The Journal of clinical psychiatry.

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.

H. Nasrallah, J. Cucchiaro, A. Loebel, 2013, Journal of psychiatric research.

Visual Abnormalities in Albino Mammals

J. Cucchiaro, 1985 .

Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

G. Sachs, J. Cucchiaro, H. Kroger, 2014, The American journal of psychiatry.

Efficacy of lurasidone across five symptom dimensions of schizophrenia: Pooled analysis of short-term, placebo-controlled studies

S. Marder, J. Cucchiaro, A. Pikalov, 2015, European Psychiatry.

Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

S. Potkin, J. Cucchiaro, A. Pikalov, 2013, Schizophrenia Research.

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial

Philip D. Harvey, R. Keefe, J. Cucchiaro, 2011, Schizophrenia Research.

A GABAergic projection from the pretectum to the dorsal lateral geniculate nucleus in the cat

S. Sherman, M. Bickford, J. Cucchiaro, 1991, Neuroscience.

Ultrastructure of synapses from the pretectum in the A‐laminae of the cat's lateral geniculate nucleus

S. Sherman, D. Uhlrich, J. Cucchiaro, 1993, The Journal of comparative neurology.

Electron‐microscopic analysis of synaptic input from the perigeniculate nucleus to the A‐laminae of the lateral geniculate nucleus in cats

S. Sherman, D. Uhlrich, J. Cucchiaro, 1991, The Journal of comparative neurology.

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

J. Cucchiaro, A. Pikalov, A. Loebel, 2017, International Journal of Bipolar Disorders.

LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY

T. Ketter, J. Cucchiaro, H. Kroger, 2016, Depression and anxiety.

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.

T. Suppes, J. Cucchiaro, A. Pikalov, 2016, The American journal of psychiatry.

The development of lurasidone for bipolar depression

J. Cucchiaro, A. Pikalov, A. Loebel, 2015, Annals of the New York Academy of Sciences.

Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.

K. Rajagopalan, T. Ketter, J. Cucchiaro, 2015, Journal of affective disorders.

Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

J. Calabrese, J. Cucchiaro, H. Kroger, 2014, The American journal of psychiatry.

GABAergic circuits in the lateral geniculate nucleus of the cat.

D. J. Uhlrich, J. Cucchiaro, 1992, Progress in brain research.

Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.

H. Meltzer, J. Cucchiaro, A. Pikalov, 2011, The American journal of psychiatry.

Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled study

J. Cucchiaro, T. Suppes, S. Targum, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.

M. DelBello, R. Goldman, J. Cucchiaro, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study

J. Kane, J. Cucchiaro, A. Pikalov, 2013, Schizophrenia Research.

Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.

M. Sajatovic, J. Cucchiaro, A. Pikalov, 2016, The Journal of clinical psychiatry.

Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.

R. McIntyre, J. Cucchiaro, A. Pikalov, 2015, The Journal of clinical psychiatry.

Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder

J. Calabrese, J. Cucchiaro, A. Pikalov, 2017, European Neuropsychopharmacology.

Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation

C. Correll, J. Kane, L. Citrome, 2015, BMC Psychiatry.

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study

L. Citrome, J. Cucchiaro, A. Loebel, 2012, International clinical psychopharmacology.

Poster #208 EFFECTIVENESS OF LURASIDONE VS. QUETIAPINE XR FOR RELAPSE PREVENTION IN SCHIZOPHRENIA: A 12-MONTH, DOUBLE-BLIND STUDY

J. Kane, J. Cucchiaro, A. Pikalov, 2012, Schizophrenia Research.

Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.

J. Cucchiaro, A. Loebel, S. Chapel, 2016, Clinical therapeutics.

Phaseolus vulgaris leucoagglutinin (PHA-L): a neuroanatomical tracer for electron microscopic analysis of synaptic circuitry in the cat's dorsal lateral geniculate nucleus.

D. J. Uhlrich, J. Cucchiaro, 1990, Journal of electron microscopy technique.

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

Philip D. Harvey, R. Keefe, J. Cucchiaro, 2011, Schizophrenia Research.

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

R. Tandon, J. Cucchiaro, A. Pikalov, 2016, Journal of psychopharmacology.

Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies

H. Nasrallah, J. Cucchiaro, A. Pikalov, 2014, CNS Spectrums.

Early development of the retinal line of decussation in normal and albino ferrets

J. Cucchiaro, 1991, The Journal of comparative neurology.

The development of the retinogeniculate pathways in normal and albino ferrets

J. Cucchiaro, R. W. Guillery, 1984, Proceedings of the Royal Society of London. Series B. Biological Sciences.

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension

Philip D. Harvey, J. Cucchiaro, A. Loebel, 2013, European Neuropsychopharmacology.

Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia

J. Cucchiaro, A. Pikalov, A. Loebel, 2015, International clinical psychopharmacology.

Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.

M. Sajatovic, J. Cucchiaro, A. Pikalov, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

C. Correll, J. Cucchiaro, A. Pikalov, 2016, CNS Spectrums.

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.

J. McEvoy, L. Citrome, J. Cucchiaro, 2013, The Journal of clinical psychiatry.

LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL

H. Meltzer, J. Cucchiaro, A. Loebel, 2010, Schizophrenia Research.

A THREE ARM DOSE FINDING STUDY OF LURASIDONE: EFFICACY AND TOLERABILITY DATA

Philip D. Harvey, J. Cucchiaro, M. Murasaki, 2010, Schizophrenia Research.

EPA-1722 – A Double-blind, Placebo-controlled, Randomized Withdrawal Study of lurasidone for the Maintenance of Efficacy in Patients with Schizophrenia

R. Tandon, J. Cucchiaro, A. Pikalov, 2014, European Psychiatry.

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

P. Weiden, J. McEvoy, C. Correll, 2013, CNS Spectrums.

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia

Philip D. Harvey, J. Cucchiaro, A. Pikalov, 2013, CNS Spectrums.